Table 1.
Demographics | Male (n=3,176) | Female, non-pregnant (n = 5,410) | Female, pregnant (n = 587) |
---|---|---|---|
Follow-up time months | 16 (7, 36) | 19 (9, 37) | 22 (8, 48) |
Age years | 36 (32, 40) | 34 (29, 38) | 30 (26, 33) |
Employed | 1642 (51.7) | 2194 (40.6) | 218 (37.1) |
History of smoking | 593 (18.7) | 264 (4.9) | 26 (4.4) |
Clinical | |||
HAART regimen | |||
d4t-3TC-EFV | 2761 (86.9) | 4580 (84.7) | 38 (6.5) |
d4t-3TC-NVP | 177 (5.6) | 473 (8.7) | 58 (9.9) |
d4t-3TC-LPVr | 48 (1.5) | 80 (1.5) | 479 (81.6) |
Weight kg | 59 (53, 66) | 57 (49, 65) | 68 (60, 77) |
Body mass index kg/m2 | 20.1 (18.3, 22.3) | 22.2 (19.4, 25.5) | 26.5 (23.3, 29.7) |
Body mass index category | |||
< 18.5 | 818 (27.1) | 927 (17.9) | 9 (1.6) |
18.5-24.9 | 1901 (63.0) | 2813 (54.3) | 198 (35.9) |
25.0-29.9 | 252 (8.4) | 961 (18.6) | 221 (40.1) |
≥ 30 | 46 (1.5) | 478 (9.2) | 123 (22.3) |
WHO stage III or IV | 1521 (47.9) | 2355 (43.5) | 105 (17.9) |
Current tuberculosis | 701 (22.1) | 957 (17.7) | 22 (3.8) |
Laboratory | |||
Hemoglobin, low‡ | 1581 (51.1) | 2884 (54.8) | 131 (31.0) |
CD4 count cells/mm3 | 74 (22, 149) | 92 (35, 162) | 156 (103, 200) |
CD4 count category | |||
≤ 50 | 1245 (40.5) | 1727 (32.9) | 48 (8.8) |
51-100 | 593 (19.3) | 1062 (20.2) | 85 (15.6) |
101-200 | 937 (30.5) | 1843 (35.1) | 280 (51.3) |
201-350 | 261 (8.5) | 508 (9.7) | 124 (22.7) |
> 350 | 40 (1.3) | 115 (2.2) | 9 (1.7) |
CD4 % | 6.3 (2.8, 10.5) | 7.2 (3.7, 11.5) | 11.6 (7.8, 15.5) |
Viral load†log10 copies/ml | 4.3 (3.6, 4.6) | 4.2 (3.5, 4.6) | 3.8 (1.7, 4.1) |
Viral load category | |||
≤ 400 | 163 (17.9) | 289 (19.1) | 31 (41.9) |
401-10,000 | 131 (14.4) | 244 (16.1) | 20 (27.0) |
> 10,000 | 615 (67.7) | 979 (64.8) | 23 (31.1) |
Categorical variables expressed as number (% total); continuous variables as median (interquartile range).
After adjustment for altitude, lower limit of normal hemoglobin is 12.35 g/dl for men and 11.35 (10.35) g/dl for non-pregnant (pregnant) women.
Viral load was missing in 71% of men, 72% of non-pregnant women, and 88% of pregnant women.